However, WSX1 expression was significantly lower in NAT (39.31% ± 8.58%, P < 0.0001) and was the lowest in HCC tissues (14.31% ± 7.95%, P < 0.0001, Fig. 1b). This evidence concerns the gene BRD2 and hepatocellular carcinoma.